Effects of Combinatory In Vitro Treatment with Immune Checkpoint Inhibitors and Cytarabine on the Anti-Cancer Immune Microenvironment in De Novo AML Patients

Effects of Combinatory In Vitro Treatment with Immune Checkpoint Inhibitors and Cytarabine on the Anti-Cancer Immune Microenvironment in De Novo AML Patients

Despite substantial progress in the diagnostic and therapeutic procedures, acute myeloid leukaemia (AML) still constitutes a significant problem for patients suffering from its relapses. A comprehensive knowledge of the disease’s molecular background has led to the development of targeted therapies,...

Full description

Bibliographic Details
Main Authors: Łukasz Bołkun, Aleksandra Starosz, Anna Krętowska-Grunwald, Tomasz Wasiluk, Alicja Walewska, Agnieszka Wierzbowska, Marcin Moniuszko, Kamil Grubczak
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
acute myeloid leukaemia
cytarabine
immune checkpoint inhibitors
CTLA-4
PD-1
PD-L1
Online Access:https://www.mdpi.com/2072-6694/16/2/462

Internet

https://www.mdpi.com/2072-6694/16/2/462

Similar Items